Cargando…

Renewed interest in the progesterone receptor in breast cancer

Detalles Bibliográficos
Autores principales:	Lim, Elgene, Palmieri, Carlo, Tilley, Wayne D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5061913/ https://www.ncbi.nlm.nih.gov/pubmed/27657336 http://dx.doi.org/10.1038/bjc.2016.303

Ejemplares similares

Comment on ‘Renewed interest in the progesterone receptor in breast cancer’
por: Simone, Giovanni, et al.
Publicado: (2017)

Renewed interests in carbonic anhydrase IX in relevance to breast cancer treatment
por: Dolatkhah, Mitra, et al.
Publicado: (2019)

Renewed Interest in Regenerative Medicine
Publicado: (2018)

Cardioembolic Infarction: A Renewed Topic of Interest
por: Arboix, Adrià
Publicado: (2010)

Roles for estrogen and progesterone in breast cancer prevention
por: Jerry, D Joseph
Publicado: (2007)

Progesterone receptor modulates estrogen receptor-α action in breast cancer
por: Mohammed, Hisham, et al.
Publicado: (2015)

Genomic agonism and phenotypic antagonism between estrogen and progesterone receptors in breast cancer
por: Singhal, Hari, et al.
Publicado: (2016)

OR05-06 The Androgen Receptor Is a Tumour Suppressor in Estrogen Receptor Positive Breast Cancer
por: Hickey, Theresa E, et al.
Publicado: (2020)

Improved relapse-free survival on aromatase inhibitors in breast cancer is associated with interaction between oestrogen receptor-α and progesterone receptor-b
por: Snell, Cameron E., et al.
Publicado: (2018)

The Role of Progesterone Receptors in Breast Cancer
por: Li, Zhuo, et al.
Publicado: (2022)

Type 1 Nuclear Receptor Activity in Breast Cancer: Translating Preclinical Insights to the Clinic
por: Kumar, Sanjeev, et al.
Publicado: (2021)

Progesterone receptors - animal models and cell signaling in breast cancer: Role of steroid receptor coactivators and corepressors of progesterone receptors in breast cancer
por: Gao, Xiuhua, et al.
Publicado: (2002)

Alternative splicing and the progesterone receptor in breast cancer
por: Cork, David MW, et al.
Publicado: (2008)

Oestrogen and progesterone receptor distribution in the cancerous breast.
por: Panahy, C., et al.
Publicado: (1987)

The role of oestrogen and progesterone receptors in breast cancer – immunohistochemical evaluation of oestrogen and progesterone receptor expression in invasive breast cancer in women
por: Badowska-Kozakiewicz, Anna M., et al.
Publicado: (2015)

RIME proteomics of estrogen and progesterone receptors in breast cancer
por: D’Santos, Clive, et al.
Publicado: (2015)

Commentary: Surface ablation: Renewed interest
por: Dave, Abhishek
Publicado: (2022)

The Renewal of Cancer Immunotherapy
por: Bulgarelli, Jenny, et al.
Publicado: (2023)

90 YEARS OF PROGESTERONE: Molecular mechanisms of progesterone receptor action on the breast cancer genome
por: Beato, Miguel, et al.
Publicado: (2020)

Progesterone receptors - animal models and cell signaling in breast cancer: Expression and transcriptional activity of progesterone receptor A and progesterone receptor B in mammalian cells
por: Graham, J Dinny, et al.
Publicado: (2002)

MicroRNA regulation of progesterone receptor in breast cancer
por: Gilam, Avital, et al.
Publicado: (2017)

MDM2 as a Rational Target for Intervention in CDK4/6 Inhibitor Resistant, Hormone Receptor Positive Breast Cancer
por: Portman, Neil, et al.
Publicado: (2021)

Progesterone receptors - animal models and cell signalling in breast cancer: Diverse activation pathways for the progesterone receptor: possible implications for breast biology and cancer
por: Lanari, Claudia, et al.
Publicado: (2002)

90 Years of progesterone: Ninety years of progesterone: the ‘other’ ovarian hormone
por: Ali, Simak, et al.
Publicado: (2020)

Power Surge: Renewed Interest in Nuclear Energy
por: Holton, W. Conard
Publicado: (2005)

Role of the progesterone receptor for paclitaxel resistance in primary breast cancer
por: Schmidt, M, et al.
Publicado: (2007)

Outcomes of Estrogen Receptor Negative and Progesterone Receptor Positive Breast Cancer
por: Chan, Melissa, et al.
Publicado: (2015)

Oral Selective Estrogen Receptor Degraders (SERDs) in Breast Cancer: Advances, Challenges, and Current Status
por: Downton, Teesha, et al.
Publicado: (2022)

Alcohol consumption and breast cancer oestrogen and progesterone receptor status
por: Enger, S M, et al.
Publicado: (1999)

Progesterone receptor gene polymorphism and risk for breast and ovarian cancer.
por: Lancaster, J. M., et al.
Publicado: (1998)

It is Time to Renew!
por: Braile, Domingo M.
Publicado: (2016)

Progesterone receptors – animal models and cell signaling in breast cancer: The role of oestrogen and progesterone receptors in human mammary development and tumorigenesis
por: Anderson, Elizabeth
Publicado: (2002)

miR-129-2 mediates down-regulation of progesterone receptor in response to progesterone in breast cancer cells
por: Godbole, Mukul, et al.
Publicado: (2017)

Progesterone suppresses the invasion and migration of breast cancer cells irrespective of their progesterone receptor status - a short report
por: Godbole, Mukul, et al.
Publicado: (2017)

Progesterone suppresses triple-negative breast cancer growth and metastasis to the brain via membrane progesterone receptor α
por: Zhou, Li, et al.
Publicado: (2017)

Expression of Estrogen Receptor- and Progesterone Receptor-Regulating MicroRNAs in Breast Cancer
por: Kalinina, Tatiana, et al.
Publicado: (2021)

Risk factors for breast cancer in young women by oestrogen receptor and progesterone receptor status
por: McCredie, M R E, et al.
Publicado: (2003)

A gene signature of loss of oestrogen receptor (ER) function and oxidative stress links ER-positive breast tumours with an absent progesterone receptor and a poor prognosis
por: Neven, Patrick, et al.
Publicado: (2008)

(64)Cu-SAR-Bombesin PET-CT Imaging in the Staging of Estrogen/Progesterone Receptor Positive, HER2 Negative Metastatic Breast Cancer Patients: Safety, Dosimetry and Feasibility in a Phase I Trial
por: Wong, Keith, et al.
Publicado: (2022)

Molecular Biomarkers for Contemporary Therapies in Hormone Receptor-Positive Breast Cancer
por: Freelander, Allegra, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7h84ga28pphardl9sauoj5lgh3